Drug
Lanabecestat clinical trials
Also written AZD3293 and LY3314814.
- studies test it
- 18
- open now
- 0
- in phase 3
- 3
- first study started
- 2012
How studies write it
Studies that test it under each name
Studies by the year they started
18 studies that test it; most in 2014 (4)
| Year | Studies |
|---|---|
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 4 |
| 2015 | 3 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 3 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 15
- Phase 2
- 1
- Phase 3
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 18 · Other 0
Often tested with
Tested in the same studies.
Contraceptives, Oral (1)
Studies
Open first, then newest update. How each study uses lanabecestat is read from its arms, and is right about nine times in ten.
Testing it · 18
- A Study of Lanabecestat (LY3314814) in Participants With Mild Alzheimer's Disease DementiaTerminatedPhase 3AstraZenecaNCT02783573Written as Lanabecestat
- A Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease DementiaTerminatedPhase 3AstraZenecaNCT02972658Written as Lanabecestat
- An Efficacy and Safety Study of Lanabecestat (LY3314814) in Early Alzheimer's DiseaseTerminatedPhase 2/3AstraZenecaNCT02245737Written as Lanabecestat
- A Drug Interaction Study of Lanabecestat (LY3314814) and Warfarin in Healthy ParticipantsCompletedPhase 1AstraZenecaNCT02540668Written as Lanabecestat
- A Drug-Drug Interaction Study of Lanabecestat (LY3314814) in Healthy ParticipantsCompletedPhase 1AstraZenecaNCT02406261Written as Lanabecestat
- A Study of Lanabecestat (LY3314814) in Healthy Participants When Taken With RosuvastatinCompletedPhase 1AstraZenecaNCT03019549Written as Lanabecestat
- A Study of Lanabecestat (LY3314814) in Healthy ParticipantsCompletedPhase 1AstraZenecaNCT02663128Written as Lanabecestat
- A Drug-drug Interaction Study of Lanabecestat (LY3314814) in Healthy ParticipantsCompletedPhase 1AstraZenecaNCT02568397Written as Lanabecestat
- A Study of LY3314814 in Healthy ParticipantsCompletedPhase 1AstraZenecaNCT03222427Written as LY3314814
- A Study of LY3314814 in Participants With Liver ImpairmentWithdrawnPhase 1Eli Lilly and CompanyNCT03499041Written as LY3314814
- A Study of Lanabecestat in Healthy Female Participants Taking Oral ContraceptiveWithdrawnPhase 1Eli Lilly and CompanyNCT03506399Written as Lanabecestat
- A Two-part Single and Multiple Dose Study to Assess the Safety , Pharmacokinetics and Effects of AZD3293 in Healthy Japanese Young and Elderly VolunteersCompletedPhase 1AstraZenecaNCT02005211Written as AZD3293
- AZD3293 Thorough QT Study in Healthy Male VolunteersCompletedPhase 1AstraZenecaNCT02040987Written as AZD3293
- A Phase I, Open-Label, Single-Center Study to Assess the Absorption, Metabolism, and Excretion of [14C]-AZD3293CompletedPhase 1AstraZenecaNCT02126514Written as AZD3293
- A Phase I Study in Healthy Volunteers to Assess the Effect of Cytochrome3A4 (CYP3A4) Inhibitors (Diltiazem and Itraconazole) on the Pharmacokinetics (PK) of AZD3293 and the Effects of AZD3293 on the Pharmacokinetics of Midazolam, a Cytochrome 3A4 and Cytochrome 3A5 (CYP3A4/CYP3A5) SubstrateCompletedPhase 1AstraZenecaNCT02010970Written as Group 1 AZD3293
- Relative Bioavailability Study to Assess Two Solid Formulations Compared to an Oral Solution of AZD3293 in Healthy Male and Non-Fertile Female SubjectsCompletedPhase 1AstraZenecaNCT02039180Written as AZD3293 oral solution
- A Two-part Multiple Dose Study to Assess the Safety and Effects of AZD3293 in Healthy Elderly and Alzheimer's PatientsCompletedPhase 1AstraZenecaNCT01795339Written as AZD3293
- A Single Dose Study to Assess the Safety, Effects, and Blood and Urine Drug Levels of AZD3293 in Healthy SubjectsCompletedPhase 1AstraZenecaNCT01739647Written as AZD3293
Given in every arm · 1 — lanabecestat is usual care beside what is tested
Codes
What other systems call lanabecestat · ClinicalTrials.gg INT000480
- MeSH (NLM) C000608388lanabecestatOne source NLM
- UNII (FDA) X8SPJ492VFLANABECESTATConfirmed FDA, NLM, Wikidata
- Wikidata Q27293694lanabecestatConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C170091LanabecestatOne source FDA
- DrugBank DB14814One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000608388 | lanabecestat | One source NLM |
| UNII (FDA) | X8SPJ492VF | LANABECESTAT | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q27293694 | lanabecestat | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C170091 | Lanabecestat | One source FDA |
| DrugBank | DB14814 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.